200 related articles for article (PubMed ID: 35619946)
41. Extracellular Vesicles: From Biomarkers to Therapeutic Tools.
Bernardi S; Balbi C
Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32878063
[TBL] [Abstract][Full Text] [Related]
42. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells.
Hayakawa T; Aoi T; Umezawa A; Ozawa K; Sato Y; Sawa Y; Matsuyama A; Yamanaka S; Yamato M
Regen Ther; 2015 Dec; 2():95-108. PubMed ID: 31245463
[TBL] [Abstract][Full Text] [Related]
43. [Current status of the regulation and development of cell therapy products in Japan].
Igarashi Y; Sato Y
Nihon Yakurigaku Zasshi; 2018; 151(6):254-259. PubMed ID: 29887575
[TBL] [Abstract][Full Text] [Related]
44. Regulatory perspectives of Japan.
Kusakabe T
Biologicals; 2015 Sep; 43(5):422-4. PubMed ID: 26028474
[TBL] [Abstract][Full Text] [Related]
45. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
46. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
[TBL] [Abstract][Full Text] [Related]
47. Platelet-Derived Extracellular Vesicles for Regenerative Medicine.
Antich-Rosselló M; Forteza-Genestra MA; Monjo M; Ramis JM
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445286
[TBL] [Abstract][Full Text] [Related]
48. Innovative Visualization and Quantification of Extracellular Vesicles Interaction with and Incorporation in Target Cells in 3D Microenvironments.
Ragni E; Palombella S; Lopa S; Talò G; Perucca Orfei C; De Luca P; Moretti M; de Girolamo L
Cells; 2020 May; 9(5):. PubMed ID: 32397409
[TBL] [Abstract][Full Text] [Related]
49. Regenerative medicine applications: An overview of clinical trials.
Petrosyan A; Martins PN; Solez K; Uygun BE; Gorantla VS; Orlando G
Front Bioeng Biotechnol; 2022; 10():942750. PubMed ID: 36507264
[TBL] [Abstract][Full Text] [Related]
50. Extracellular Vesicle Therapeutics in Regenerative Medicine.
Imafuku A; Sjoqvist S
Adv Exp Med Biol; 2021; 1312():131-138. PubMed ID: 33330962
[TBL] [Abstract][Full Text] [Related]
51. NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine.
Codispoti B; Marrelli M; Paduano F; Tatullo M
J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30326618
[TBL] [Abstract][Full Text] [Related]
52. GMP-compliant manufacturing of biologically active cell-derived vesicles produced by extrusion technology.
Lau HC; Han DW; Park J; Lehner E; Kals C; Arzt C; Bayer E; Auer D; Schally T; Grasmann E; Fang H; Lee JY; Lee HS; Han J; Gimona M; Rohde E; Bae S; Oh SW
J Extracell Biol; 2022 Dec; 1(12):e70. PubMed ID: 38938599
[TBL] [Abstract][Full Text] [Related]
53. Adipose-derived stem cell extracellular vesicles: A systematic review
Wong DE; Banyard DA; Santos PJF; Sayadi LR; Evans GRD; Widgerow AD
J Plast Reconstr Aesthet Surg; 2019 Jul; 72(7):1207-1218. PubMed ID: 30952587
[TBL] [Abstract][Full Text] [Related]
54. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
Pachler K; Lener T; Streif D; Dunai ZA; Desgeorges A; Feichtner M; Öller M; Schallmoser K; Rohde E; Gimona M
Cytotherapy; 2017 Apr; 19(4):458-472. PubMed ID: 28188071
[TBL] [Abstract][Full Text] [Related]
55. Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
Gimona M; Pachler K; Laner-Plamberger S; Schallmoser K; Rohde E
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587212
[TBL] [Abstract][Full Text] [Related]
56. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
[TBL] [Abstract][Full Text] [Related]
57. Development of extracellular vesicle-based medicinal products: A position paper of the group "Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France".
Silva AKA; Morille M; Piffoux M; Arumugam S; Mauduit P; Larghero J; Bianchi A; Aubertin K; Blanc-Brude O; Noël D; Velot E; Ravel C; Elie-Caille C; Sebbagh A; Boulanger C; Wilhelm C; Rahmi G; Raymond-Letron I; Cherukula K; Montier T; Martinaud C; Bach JM; Favre-Bulle O; Spadavecchia J; Jorgensen C; Menasché P; Aussel C; Chopineau J; Mosser M; Ullah M; Sailliet N; Luciani N; Mathieu N; Rautou PE; Brouard S; Boireau W; Jauliac S; Dedier M; Trouvin JH; Gazeau F; Trouillas M; Peltzer J; Monsel A; Banzet S
Adv Drug Deliv Rev; 2021 Dec; 179():114001. PubMed ID: 34673131
[TBL] [Abstract][Full Text] [Related]
58. Regulatory Aspects of Cell and Gene Therapy Products: The Japanese Perspective.
Maruyama Y; Noda S; Okudaira S; Sakurai A; Okura N; Honda F
Adv Exp Med Biol; 2023; 1430():155-179. PubMed ID: 37526847
[TBL] [Abstract][Full Text] [Related]
59. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
60. The potential roles of stem cell-derived extracellular vesicles as a therapeutic tool.
Huang YC; Lai LC
Ann Transl Med; 2019 Nov; 7(22):693. PubMed ID: 31930094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
